Search clinical trials for: Pathologic complete remission

Total 10000 results

Peking University People's Hospital
Shanxi Province Cancer Hospital; Cancer Institute and Hospital, Chinese Academy... and other collaborators

Recruiting

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors (N01-A-PICIT-GT)

Cervical Cancer | Breast Cancer | Ovarian Cancer | Fallopian Tube Cancer | Non-Small Cell Lung Cancer | Lung Cancer | Primary Peritoneal Cancer | Chemotherapy-Induced Thrombocytopenia | Gynecologic Cancers | Persistent Isolated Chemotherapy-Induced Thrombocytopenia

China
Peking University People's Hospital
Shanxi Province Cancer Hospital; Cancer Institute and Hospital, Chinese Academy... and other collaborators

Recruiting

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors (N01-A-PICIT-GI)

Gastrointestinal Neoplasms | Colorectal Cancer | Pancreatic Cancer | Chemotherapy-Induced Thrombocytopenia | Persistent Isolated Chemotherapy-Induced Thrombocytopenia

China
Rong Tao

Recruiting

Chidamide Maintenance for MRD-Positive Double-Expressor DLBCL in First Complete Remission (DEL-MRD-CHID)

Diffuse Large B-Cell Lymphoma

China
Rigshospitalet, Denmark

Recruiting

Complete Remission After Treatment With Biologics for Nasal Polyps

Nasal Polyps

Denmark
Kyorin University
Japan Clinical Oncology Group; National Cancer Center, Japan; Ono Pharmaceutical...

Recruiting

Tirabrutinib Maintenance Versus Placebo in Patients With Primary CNS Lymphoma in Complete Remission (JCOG2104) (TIMELY-pII)

Primary Central Nervous System Lymphoma

Japan

Search clinical trials for: Pathologic complete remission

This is a preview